Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events-Reference-Cited by-同舟云学术

Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events

Published:2019-12-01 Issue:12 Volume:4 Page:1214
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Verma Subodh¹,Bain Stephen C.²,Buse John B.³,Idorn Thomas⁴,Rasmussen Søren⁴,Ørsted David D.⁴,Nauck Michael A.⁵

Affiliation:

1. Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada

2. Diabetes Research Unit Cymru, Swansea University Medical School, Swansea, United Kingdom

3. Department of Medicine, University of North Carolina School of Medicine at Chapel Hill, Chapel Hill

4. Novo Nordisk A/S, Søborg, Denmark

5. Diabetes Center Bochum-Hattingen, St Josef Hospital (Ruhr-Universität Bochum), Bochum, Germany

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2754760/jamacardiology_verma_2019_oi_190052.pdf

Reference20 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.;Zinman;N Engl J Med,2015

2. Liraglutide and cardiovascular outcomes in type 2 diabetes.;Marso;N Engl J Med,2016

3. Effect of liraglutide on cardiovascular events in patients with type 2 diabetes mellitus and polyvascular disease: results of the LEADER trial.;Verma;Circulation,2018

4. Liraglutide reduces cardiovascular events and mortality in type 2 diabetes mellitus independently of baseline low-density lipoprotein cholesterol levels and statin use: results from the LEADER trial.;Verma;Circulation,2018

5. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes.;Marso;N Engl J Med,2016

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of triglyceride-glucose index with adverse cardiovascular events in patients with established coronary artery disease according to different inflammatory status;Nutrition, Metabolism and Cardiovascular Diseases;2024-09

2. Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo;Archivos de Cardiología de México;2024-06-05

3. Comparison of cardiovascular outcomes of new antihyperglycemic agents in Type 2 Diabetes Mellitus: a meta‐analysis;ESC Heart Failure;2024-02-28

4. [Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases;Actas Dermo-Sifiliográficas;2024-01

5. Agonistas del receptor de GLP-1 para el tratamiento de la obesidad en pacientes con dermatosis inmunomediadas;Actas Dermo-Sifiliográficas;2024-01